Grants > Visual System Vulnerability In Dementia: From Detection To Determinants Updated On: Jul 2, 2026
Alzheimer's Disease Research Grant

Visual System Vulnerability In Dementia: From Detection To Determinants

Genomics
Keir Yong, PhD.

Principal Investigator

Keir Yong, PhD

University College London

London, United Kingdom

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$291,739.19

Active Dates

July 01, 2026 - June 30, 2029

Grant ID

A2026032S

Co-Principal Investigator(s)

David Cash, PhD, University College London Institute of Neurology

Andre Altmann, PhD, University College London

Goals

This project aims to compare genetic factors associated with vulnerability of the brain’s visual networks with forms of Alzheimer’s disease characterized by predominant visual loss.

Summary

Cortical visual (‘brainsight’ not eyesight loss) is the earliest sign of dementia for people with posterior cortical atrophy, in whom vulnerability of the brain’s visual rather than memory system causes ‘visual-led Alzheimer’s disease’.
We will use a novel brainsight test and brain scans from 35,000 volunteers in a national ageing study (UK Biobank) to improve detection of visual system vulnerability.
We will compare genetic risk factors associated with visual system vulnerability and visual-led Alzheimer’s disease to determine why Alzheimer’s disease may affect people in different ways.

Unique and Innovative

People with ‘brainsight’ loss are often misdiagnosed as having eye conditions. We will use a novel test to detect and distinguish dementia-related ‘brainsight’ from eyesight loss.

Understanding risks for visual-led Alzheimer’s disease (AD) has been limited by diagnostic challenges and small sample sizes. We will compare genetic factors associated with visual system vulnerability in the largest neuroimaging study worldwide with the largest genetic studies of visual-led forms of AD.

Foreseeable Benefits

• Improved detection of brainsight loss across research and clinical settings.
• Understanding why Alzheimer’s disease may particularly attack the brain’s visual rather than memory system.
• Informing future research to identify treatments better tailored to the type of Alzheimer’s disease one is affected by.